ACCESSION: MSBNK-SMB_Measured-HSA015P0114016
RECORD_TITLE: Characterized; Epsilon-caprolactam; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL03_pos_1222': {'bp': 8704928.0, 'sum': 16557544.0}, 'EL16_pos_1174': {'bp': 3812956.0, 'sum': 7475546.0}, 'EL20_pos_1168': {'bp': 2614712.0, 'sum': 6156596.0}, 'EL12_pos_1174': {'bp': 3120242.0, 'sum': 6912878.0}, 'EL18_pos_1174': {'bp': 4575172.0, 'sum': 8152795.0}, 'EL14_pos_1174': {'bp': 2338285.0, 'sum': 5703108.0}, 'EL04_pos_1180': {'bp': 2670203.0, 'sum': 6106501.0}, 'EL23_pos_1180': {'bp': 4728952.0, 'sum': 8892326.0}, 'EL22_pos_1180': {'bp': 3871145.0, 'sum': 8273544.0}, 'EL17_pos_1168': {'bp': 2566700.0, 'sum': 6464975.0}, 'EL06_pos_1174': {'bp': 2957174.0, 'sum': 6844467.0}, 'EL19_pos_1180': {'bp': 3329811.0, 'sum': 7498555.0}, 'EL05_pos_1174': {'bp': 4067344.0, 'sum': 8266539.0}, 'EL02_pos_1174': {'bp': 3311038.0, 'sum': 7630637.0}, 'EL07_pos_1174': {'bp': 5498365.0, 'sum': 9701741.0}, 'EL01_pos_1174': {'bp': 4591958.0, 'sum': 8026169.0}, 'EL24_pos_1186': {'bp': 3736263.0, 'sum': 7137910.0}, 'EL11_pos_1174': {'bp': 3639577.0, 'sum': 7295668.0}, 'EL21_pos_1174': {'bp': 4934032.0, 'sum': 9222016.0}, 'EL10_pos_1174': {'bp': 4165047.0, 'sum': 7586487.0}, 'EL09_pos_1174': {'bp': 4028369.0, 'sum': 7538185.0}, 'EL15_pos_1174': {'bp': 3429831.0, 'sum': 7408187.0}, 'EL08_pos_1174': {'bp': 6016812.0, 'sum': 9839016.0}, 'EL13_pos_1174': {'bp': 4729548.0, 'sum': 8351424.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 114.091732
COMMENT: PRECURSOR_M/Z_STDEV 0.000042
COMMENT: PRECURSOR_IN_MS1 mz 114.091320; int 47.056; delta(ppm) 0.688585
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.195; C6H11NO; [M+H]+; delta(ppm) -0.194546
COMMENT: PROPOSED_MF MS-FINDER 3.644; C6H11NO; [M+H]+; delta(ppm) -0.196441
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.546; C6H11NO; [M+H]+; delta(ppm) -0.196441
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) -0.196441
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.714; C6H11NO; [M+H]+; delta(ppm) -0.196441
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.814; C4H9N4; [M+H]+; delta(ppm) 11.572017
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) -0.196441
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.344; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; ON=C1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.179; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; O=C(C(=CN)C)CC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.162; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; CC(=O)C1CCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.077; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; CCC1C(=O)CCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.071; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; C\C=C(/C)CC(N)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.879; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.748; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.740; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.740; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.705; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.653; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.653; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.647; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.601; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.554; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.539; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.526; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.497; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.493; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.474; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.462; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.462; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.462; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.441; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.441; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.434; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.434; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.428; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.411; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.392; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.376; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.983; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.629; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.616; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.601; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.599; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.592; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.543; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.486; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.456; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.455; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.443; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.432; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.401; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.370; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.347; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.341; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.292; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.288; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.284; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.126; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.087; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.062; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.062; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.671; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; azepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.011; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.709; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.438; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; N-cyclohexylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.218; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; UXKZFJDNFBNQHE-RITPCOANSA-N; [M+H]+; [(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; XRLDSWLMHUQECH-UHFFFAOYSA-N; [M+H]+; cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; BWKHTRYJANAUCO-UHFFFAOYSA-N; [M+H]+; 2-aminospiro[2.3]hexan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; NWIIFKYGKOLKML-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopent-3-en-1-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; UHSSZVLSEAEFTI-UHFFFAOYSA-N; [M+H]+; (3-amino-1-bicyclo[1.1.1]pentanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; WYQKKRBHVXDDTB-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)bicyclo[1.1.1]pentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; AAQLNWLDUWCQOD-LURJTMIESA-N; [M+H]+; (2S)-2-aminohex-5-yn-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; JUUPISMKQGJUEL-UHFFFAOYSA-N; [M+H]+; 1-aminohex-5-yn-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; YGYOQZPGFXHQMW-XEAPYIEGSA-N; [M+H]+; [(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; BHIQRZLQBMERJY-UHFFFAOYSA-N; [M+H]+; 5-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; QQIZPINZVQELRS-UHFFFAOYSA-N; [M+H]+; 1-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; LMDVLNHRTIBTGT-UHFFFAOYSA-N; [M+H]+; 4-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; VQIILGJJJQKLPC-PBXRRBTRSA-N; [M+H]+; (1R,5R,6S)-2-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; JXSAWOLLGHOTJJ-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; XFBQQBXIYXFYKY-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; OOMIMZFFLZQKIU-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; SEHVUORORNIEOB-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.0]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; NZCBOEIGQAQLCD-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[4.1.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; YXNPVBNVXFDPHF-NTSWFWBYSA-N; [M+H]+; (1S,6S)-3-azabicyclo[4.1.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; VOABPFRENHXUQX-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; XSGGQEPWEZULLB-WDSKDSINSA-N; [M+H]+; (1R,5S)-3-azabicyclo[3.2.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; SFEYJTLKTWQWMB-HSUXUTPPSA-N; [M+H]+; [(1R,2S,5S)-3-azabicyclo[3.1.0]hexan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.990; RJFSZMRLRWNKCP-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[3.1.1]heptan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; BOTJOIYABJNMEW-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; LSSWTAXATYJJOT-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; IXXBUEAWNGTYSS-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; TWQMJAQGXUVGOA-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.974; YBZQRYWKYBZZNT-BYPYZUCNSA-N; [M+H]+; (1R)-2,2-dimethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; OUFBLTGDJDQVTA-UHFFFAOYSA-N; [M+H]+; 2-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; MNJYWTHQNUBTIC-RITPCOANSA-N; [M+H]+; (2S,3R)-2-ethenyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; AWZIRBSKQVRHQS-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.1.0]hexan-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; ILYYOUOYMCOHSN-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; JPXSWTRRFQUJTC-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; JNABLKYNVDCEJC-UHFFFAOYSA-N; [M+H]+; 1-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; QTSOGHFBXHIBFM-HCWXCVPCSA-N; [M+H]+; (1R,5S,6S)-2-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; DVOBWGYOTJOCAJ-UHFFFAOYSA-N; [M+H]+; 3,4-dihydro-2H-pyran-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; QOQPLUHKCHMZSQ-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; GTYBCXLDMBKOHV-NTSWFWBYSA-N; [M+H]+; (1R,6S)-3-oxabicyclo[4.1.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; HEOZZUBPQNUUPG-HSUXUTPPSA-N; [M+H]+; (1R,6R,7R)-2-oxabicyclo[4.1.0]heptan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.954; OTCYOBLTAQTFPW-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; KMLPEYHLAKSCGX-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; AFLIGFFKSOPBNA-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; SSZMVNBVJGCVFK-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; BKHTZJDZHRFTEW-UHFFFAOYSA-N; [M+H]+; 1,2,3,6-tetrahydropyridin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; SZEYBIHWBKIRJG-UHFFFAOYSA-N; [M+H]+; 4-oxaspiro[2.4]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; WHCQIGAGLHHFPZ-JKUQZMGJSA-N; [M+H]+; (1S,4S,6R)-2-oxabicyclo[2.2.1]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; ZFDMYXRXSBKBLF-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[3.1.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; GMXKRJFFSCDIAQ-UHFFFAOYSA-N; [M+H]+; 1-[1-(aminomethyl)cyclopropyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; YJOCNEVFWOGVQR-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.2.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; NVHRHGWRVNFFIB-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; PNBUAUKWRXPJFK-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; AHVAATWZOGWTOX-UHFFFAOYSA-N; [M+H]+; 1-methyl-2-oxabicyclo[2.1.1]hexan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; YOQFMSBXAJNJJA-UHFFFAOYSA-N; [M+H]+; 1-amino-3-cyclopropylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; HZAPWKALBWQUQD-UHFFFAOYSA-N; [M+H]+; 2-amino-1-cyclobutylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; YFSGRMONVCFYTC-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-2,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; XBZJFFHSLIVHCZ-NGJCXOISSA-N; [M+H]+; (1S,2R,4R)-7-azabicyclo[2.2.1]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.859; POOPWPIOIMBTOH-UHFFFAOYSA-N; [M+H]+; 8-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; DZOONCSMZVPSHJ-UHFFFAOYSA-N; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; QWJRZIUNOYNJIQ-UHFFFAOYSA-N; [M+H]+; 2-ethyl-2-hydroxybutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.781; XPMMAKUHNMSONL-UHFFFAOYSA-N; [M+H]+; 6-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.724; ZHAIMJRKJKQNQI-UHFFFAOYSA-N; [M+H]+; 2-oxa-7-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; MNILDQSRDHCFJG-UHFFFAOYSA-N; [M+H]+; 3-oxa-8-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.720; HQQVXVKQOPZRBJ-UHFFFAOYSA-N; [M+H]+; 3,3a,4,5,6,6a-hexahydro-1H-furo[3,4-c]pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.718; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.709; BCNBMSZKALBQEF-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; QMXPTUUFGSTIKK-UHFFFAOYSA-N; [M+H]+; 5-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; QPJCYJIZFCJYIR-UHFFFAOYSA-N; [M+H]+; 4-propylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.707; ZRBMHTFPJMSUDJ-UHFFFAOYSA-N; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.706; ZBCUGJNJBOSHIA-UHFFFAOYSA-N; [M+H]+; 4-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.705; KTWRIXHINMYODR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.704; GMHPWGYTSXHHPI-UHFFFAOYSA-N; [M+H]+; azepan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.704; QRWZCJXEAOZAAW-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; SGNDFJVXTXKBGO-PHDIDXHHSA-N; [M+H]+; (1S,6R)-8-oxa-3-azabicyclo[4.2.0]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.700; DOTBWZRLSYDMSC-LURJTMIESA-N; [M+H]+; (2S)-2-hydroxy-2-methylpentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.700; VKIGAWAEXPTIOL-LURJTMIESA-N; [M+H]+; (2S)-2-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; QJIFFAMGOQBKPK-UHFFFAOYSA-N; [M+H]+; 6-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; PHGAOXNFCZKFTR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; IYZVTTRRGCJXGK-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; FYCFJMPASVKULQ-UHFFFAOYSA-N; [M+H]+; 1-pyrrolidin-2-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.698; PTSGHGGLRADEFP-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.696; NSRPFJGOCZUUHE-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.693; IAXUBUNOIDLOLR-UHFFFAOYSA-N; [M+H]+; 3,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; ZTXSXVWHVLDJQB-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; HGVPKAGCVCGRDQ-UHFFFAOYSA-N; [M+H]+; 4,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; UWJKJTAFQCZBLA-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-2,2-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; LNDYIZFLFMYMEO-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-2,2-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.653; UUTGCNVYKLQLRV-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.649; XKDPBYCPNJRCSM-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.648; URLVRPKEOGBFHJ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.641; UMECPVGLNIYFEO-UHFFFAOYSA-N; [M+H]+; 4-propan-2-ylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.640; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -63.547; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.393; XRLDSWLMHUQECH; [M+H]+; Cyclopentancarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.357; ZRBMHTFPJMSUDJ; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.838; XHLCYFVJQKWNRH; [M+H]+; Piperidine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.743; PHGAOXNFCZKFTR; [M+H]+; 3-Methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.145; VEZUQRBDRNJBJY; [M+H]+; Antioxidant D
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.807; FYCFJMPASVKULQ; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.509; VRVUKQWNRPNACD; [M+H]+; pentylisocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.287; DVOBWGYOTJOCAJ; [M+H]+; 2H-Pyran, 3,4-dihydro-2-aminomethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.153; XPMMAKUHNMSONL; [M+H]+; zlchem 1132
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.832; UXKZFJDNFBNQHE; [M+H]+; ((1s,4r)-4-aminocyclopent-2-enyl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.691; GGYVTHJIUNGKFZ; [M+H]+; N-methylpiperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.990; ZFPGARUNNKGOBB; [M+H]+; N-Ethylpyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.886; QPJCYJIZFCJYIR; [M+H]+; beta-Caprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.808; SIKTVUHUQZNEPY; [M+H]+; 1-Methyl-3-piperidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.028; YGYOQZPGFXHQMW; [M+H]+; azabicyclohexanylmethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.996; FDCJCIRHYZNLDV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.699; GXCJLVVUIVSLOQ; [M+H]+; 2-Propyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.123; HUUPVABNAQUEJW; [M+H]+; zlchem 508
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.413; YBZQRYWKYBZZNT; [M+H]+; ACMC-20dplt
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.555; RBCSSAWYWYRREH; [M+H]+; 3-propoxypropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.736; UHSSZVLSEAEFTI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.944; UFWIDNCIQKQRIJ; [M+H]+; Butyrylethylenimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.534; BMSYXLRQGIFLFO; [M+H]+; 3-Isopropoxypropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.431; UWJKJTAFQCZBLA; [M+H]+; Butanenitrile, 4-hydroxy-2,2-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.904; KUQSQOIIMSDGFF; [M+H]+; Hexahydro-furo[2,3-c]pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.437; ZHAIMJRKJKQNQI; [M+H]+; 2-oxa-6-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.623; YNTUHDRALXNDEQ; [M+H]+; o-Methylvalerolactim
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.654; HOSRHDUJWMTWRD; [M+H]+; Pentane, 2-isocyanato-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.692; HGVPKAGCVCGRDQ; [M+H]+; 4,4-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.557; QWJRZIUNOYNJIQ; [M+H]+; 3-Pentanone cyanohydrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.257; TWQMJAQGXUVGOA; [M+H]+; 2-Azabicyclo[2.1.1]hexane-1-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.101; USXSCBCCYNVIPN; [M+H]+; (3-Bromo-phenyl)-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.769; DZOONCSMZVPSHJ; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.569; BCNBMSZKALBQEF; [M+H]+; Pyrrolidinone, dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.994; FILVIKOEJGORQS; [M+H]+; 1,5-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.237; VCUVETGKTILCLC; [M+H]+; Lopac-D-5766
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.001; QCKRFEBWZBKGTR; [M+H]+; 2-hydroxy-2,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.546; QZSYZIDYWNAACS; [M+H]+; 4-ethyl-2,3-dihydro-1,4-oxazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.828; WXYJAPNVTUNRQN; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.490; ZCYVBYQBOWLNBU; [M+H]+; 1-(2-Methyl-1-oxopropyl)aziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.385; IVKKELNYLUICGF; [M+H]+; 1-hydroxy-2,2-dimethyl-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.630; GORGQKRVQGXVEB; [M+H]+; N-Ethyl-N-vinylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.181; RHDNNKQDLVQQLJ; [M+H]+; 1-(propan-2-yl)aziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.062; FVEZUCIZWRDMSJ; [M+H]+; 2-Isopropyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.521; FEWLNYSYJNLUOO; [M+H]+; Formylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.333; WDFKEEALECCKTJ; [M+H]+; N-propyl-2-propenamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.600; SAOOLIIHRNLCBT; [M+H]+; ACMC-20maot
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.382; LJJFNFYPZOHRHM; [M+H]+; Sestamibi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.774; DVQLGAFYVKJEDE; [M+H]+; NN-Dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.220; CEMLHCYKDRPMSS; [M+H]+; Methoxypivalonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.629; MJVIZWIQHKRBPI; [M+H]+; Aethoxen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.813; QPWSKIGAQZAJKS; [M+H]+; 4-(dimethylamino)-3-buten-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.560; YFSGRMONVCFYTC; [M+H]+; ACMC-20aoff
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.001; FNMKFVXIVPDFBL; [M+H]+; 4-Methylaminopent-3-en-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.373; AOCHNXXMYIQWEH; [M+H]+; Oxazole, 4,5-dihydro-2,4,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -296.981; QNILTEGFHQSKFF; [M+H]+; Nipam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.012; HZRZMHNRCSIQFT; [M+H]+; 2,4,4-trimethyl-5H-oxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.071; JGAMOQYFDMQPRJ; [M+H]+; 3-(Dimethylamino)methacrylaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.986; XEXRMKMMZOZZIF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.507; QRWZCJXEAOZAAW; [M+H]+; N,N,2-Trimethylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -394.127; GZTXSSQZAMMARW; [M+H]+; 3,4,4-trimethyl-5H-1,3-oxazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.788; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.681; XRLDSWLMHUQECH; [M+H]+; Cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.995; OTCYOBLTAQTFPW; [M+H]+; (4-Oxocyclohexyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.076; OKBBHAGZRNKJPR; [M+H]+; 6-Hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.321; VEZUQRBDRNJBJY; [M+H]+; N-cyclohexylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.989; UHSSZVLSEAEFTI; [M+H]+; {3-Aminobicyclo[1.1.1]pentan-1-yl}methanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.350; VRVUKQWNRPNACD; [M+H]+; Pentyl isocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.401; FDCJCIRHYZNLDV; [M+H]+; 3-methylpent-3-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.838; YICILWNDMQTUIY; [M+H]+; Propylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.937; XHLCYFVJQKWNRH; [M+H]+; Piperidine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.068; DVOBWGYOTJOCAJ; [M+H]+; 2H-Pyran, 3,4-dihydro-2-aminomethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.296; XRLDSWLMHUQECH; [M+H]+; Cyclopentanecarboxamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, Epsilon-caprolactam, JBKVHLHDHHXQEQ-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (10), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0062769;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H11NO
CH$EXACT_MASS: 113.084064
CH$SMILES: C1CCC(=O)NCC1
CH$IUPAC: InChI=1S/C6H11NO/c8-6-4-2-1-3-5-7-6/h1-5H2,(H,7,8)
CH$LINK: CHEBI CHEBI:28579
CH$LINK: HMDB HMDB0062769
CH$NAME: epsilon-Caprolactam
CH$NAME: Epsilon-caprolactam
CH$NAME: azepan-2-one
CH$LINK: INCHIKEY JBKVHLHDHHXQEQ-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:7768
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.892
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 114.091318
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9400000000-dd9f694b3d1f03588c21
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0181199 7.9291 55.018828 1.1996 2.15 0.3143 20 f{C3H3O1}/5.07ppm,p-C3H9N1
  55.0545043 10.3669 55.055212 1.0717 3.01 0.2835 24 f{C4H7}/5.04ppm,p-C2H5N1O1
  67.0543837 12.2136 67.055125 0.8948 4.21 0.2302 23 f{C5H7}/2.34ppm,p-C1H5N1O1
  68.0496293 13.4570 68.050372 0.9699 4.43 0.4704 24 f{C4H6N1}/2.26ppm,p-C2H6O1
  69.0336422 14.0883 69.034385 0.9416 4.62 0.5682 23 f{C4H5O1}/2.19ppm,p-C2H7N1
  69.0700295 58.8475 69.070773 0.5936 15.06 0.8504 24 f{C5H9}/2.21ppm,p-C1H3N1O1
  70.0652734 999.0000 70.066017 0.2997 0.00 0.1974 24 f{C4H8N1}/2.11ppm,p-C2H4O1
  72.9372353 19.4237 72.937978 0.9460 5.13 0.3484 22 ?
  79.0543007 77.3989 79.055033 0.4174 18.64 0.7670 24 f{C6H7}/0.94ppm,p-H5N1O1
  96.0807913 48.0107 96.081436 0.5412 13.57 0.8322 24 f{C6H10N1}/0.16ppm,p-H2O1
  97.0648019 18.3021 97.065439 1.1642 5.26 0.6070 22 f{C6H9O1}/0.11ppm,p-H3N1
  112.9998778 41.0322 113.000377 0.9469 24.57 0.2817 24 ?
  113.0598303 12.5805 113.060329 1.0437 5.22 0.4071 22 ?
  114.0913636 458.0956 114.091855 0.3068 113.95 1.0000 24 f{C6H12N1O1}/0.20ppm,p
  115.0946990 32.4005 115.095182 1.0774 8.97 0.7500 23 ?
  116.0706309 132.3570 116.071105 0.4308 10.23 0.1817 24 ?
PK$NUM_PEAK: 16
PK$PEAK: m/z int. rel.int.
  55.018120 7.93 7
  55.054504 10.37 10
  67.054384 12.21 12
  68.049629 13.46 13
  69.033642 14.09 14
  69.070030 58.85 58
  70.065273 999.00 999
  72.937235 19.42 19
  79.054301 77.40 77
  96.080791 48.01 48
  97.064802 18.30 18
  112.999878 41.03 41
  113.059830 12.58 12
  114.091364 458.10 458
  115.094699 32.40 32
  116.070631 132.36 132
//
